Piriton 120ml (chlorpheniramine): Uses, Dosage & Side Effects

What it's for (Indications)

Chlorpheniramine is an antihistamine primarily indicated for the symptomatic relief of allergic conditions.
This includes perennial and seasonal allergic rhinitis, commonly manifesting as sneezing, rhinorrhea (runny nose), and watery, itchy eyes.
It is also effective in alleviating symptoms associated with the common cold, such as sneezing and rhinorrhea, though it does not treat the underlying viral infection.
Furthermore, chlorpheniramine is used to manage allergic dermatological reactions, including pruritus (itching) and urticaria (hives), providing relief from discomfort.
Its antihistaminic properties make it a valuable agent for reducing histamine-mediated responses in various allergic presentations, thereby improving the patient's quality of life during allergic episodes.

Dosage Information

Type	Guideline
Standard	The dosage of chlorpheniramine varies based on the patient's age, specific formulation, and the severity of symptoms. For adults and children 12 years of age and older, the typical oral dosage is 4 mg every 4 to 6 hours, not to exceed 24 mg in 24 hours. For children aged 6 to 11 years, the recommended dosage is 2 mg every 4 to 6 hours, with a maximum of 12 mg in 24 hours. Liquid formulations are available for precise pediatric dosing. Extended-release formulations may allow for less frequent administration, typically every 8 to 12 hours. It is crucial to adhere strictly to the prescribed or package-insert dosing instructions and to avoid exceeding the maximum daily dose to prevent potential adverse effects, particularly central nervous system depression and anticholinergic side effects. Dosage adjustments may be necessary in patients with renal or hepatic impairment.

Type

Guideline

Standard

The dosage of chlorpheniramine varies based on the patient's age, specific formulation, and the severity of symptoms. For adults and children 12 years of age and older, the typical oral dosage is 4 mg every 4 to 6 hours, not to exceed 24 mg in 24 hours. For children aged 6 to 11 years, the recommended dosage is 2 mg every 4 to 6 hours, with a maximum of 12 mg in 24 hours. Liquid formulations are available for precise pediatric dosing. Extended-release formulations may allow for less frequent administration, typically every 8 to 12 hours. It is crucial to adhere strictly to the prescribed or package-insert dosing instructions and to avoid exceeding the maximum daily dose to prevent potential adverse effects, particularly central nervous system depression and anticholinergic side effects. Dosage adjustments may be necessary in patients with renal or hepatic impairment.

Safety & Warnings

Common Side Effects

Chlorpheniramine, like other first-generation antihistamines, commonly causes central nervous system (CNS) depressant effects.
The most frequent side effect is drowsiness, which can impair the ability to perform tasks requiring mental alertness, such as driving or operating heavy machinery.
Other common CNS effects include dizziness, fatigue, and impaired coordination.
Anticholinergic side effects are also prevalent and include dry mouth, blurred vision, urinary retention, and constipation.
Less common but serious side effects can include paradoxical excitement, especially in children and the elderly, characterized by restlessness, insomnia, or tremors.
Cardiovascular effects like palpitations or tachycardia may occur.
Hypersensitivity reactions are rare but possible.
Patients should be advised to monitor for these effects and report any severe or persistent symptoms to their healthcare provider.

Serious Warnings

Black Box Warning: Chlorpheniramine does not carry an FDA-mandated Black Box Warning. However, serious warnings regarding its use warrant significant attention due to potential for significant adverse events. **Serious Warnings:** This medication can cause marked drowsiness, sedation, and impaired mental and physical abilities, which can be dangerous when operating machinery, driving a vehicle, or performing other activities requiring alertness. Concomitant use with alcohol or other central nervous system depressants significantly exacerbates these effects. Due to its anticholinergic properties, caution is advised in elderly patients, who are more susceptible to adverse effects such as confusion, urinary retention, and increased risk of falls. There is also a risk of paradoxical excitation, particularly in young children. Overdosage can be life-threatening, manifesting as severe CNS depression or stimulation, convulsions, and cardiovascular collapse. This medication should be kept out of reach of children.
Patients should be cautioned against the concomitant use of chlorpheniramine with alcohol or other central nervous system (CNS) depressants, including sedatives, tranquilizers, or anxiolytics, as this can significantly potentiate drowsiness and sedation, leading to severe impairment of cognitive and motor function.
Due to its anticholinergic properties, chlorpheniramine should be used with extreme caution in patients with conditions such as narrow-angle glaucoma, prostatic hypertrophy or other genitourinary obstructions, and pyloroduodenal obstruction, as it can exacerbate these conditions.
Elderly patients are particularly susceptible to CNS side effects, including confusion, sedation, and paradoxical excitation, as well as anticholinergic effects, warranting careful monitoring and potentially lower doses.
Patients engaged in activities requiring mental alertness should be advised of the potential for impairment.

How it Works (Mechanism of Action)

Chlorpheniramine maleate is a first-generation antihistamine belonging to the alkylamine class. Its primary mechanism of action involves competitively antagonizing histamine at peripheral H1-receptors. Histamine, an endogenous amine released during allergic reactions, binds to H1-receptors to produce symptoms such as vasodilation, increased capillary permeability, pruritus, and smooth muscle contraction. By blocking these H1-receptors, chlorpheniramine effectively inhibits the histamine-mediated responses, thereby alleviating symptoms of allergic rhinitis, urticaria, and other allergic manifestations. As a first-generation antihistamine, chlorpheniramine is lipophilic and readily crosses the blood-brain barrier, which accounts for its common central nervous system side effects, including sedation. It also possesses mild anticholinergic activity, contributing to its profile of adverse effects.